|Articles|April 24, 2006

Accredo wins Flolan agreement

Accredo Health Group, a subsidiary of Medco, won a five-yearcontract as the sole specialty pharmacy for Flolan (epoprostenolsodium, Myogen) for pulmonary arterial hypertension (PAH). Terms ofthe deal were not announced.

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.


Latest CME